Plain-English translation of NCT06342401 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Colorectal Cancer research guide →Researchers are developing and testing a new blood-based screening test to detect colorectal cancer in younger adults (under age 50). The test looks for tiny pieces of genetic material called microRNAs that are released into the bloodstream by cancer cells. This study aims to create a simple, non-invasive way to catch colorectal cancer earlier, when treatment is more likely to be successful.
Colorectal cancer in younger people is becoming more common and is expected to increase significantly over the next decade. Current screening methods like colonoscopy are invasive and uncomfortable, which discourages many younger adults from getting screened. This medication aims to fill that gap by offering an easy blood test that could catch cancer early and encourage more people to participate in screening.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will donate a blood sample that researchers will use to develop and test the new screening test. The study is divided into two parts: first, researchers will use your sample to develop and train the test using machine learning; then, they will validate the test in a separate group of participants. Your involvement is primarily a one-time blood draw, though the research itself will take place over time as scientists analyze the samples and refine the test.
AI-generated summary from trial data · Jul 9, 2026 · Not medical advice
United States
Italy
Japan